[{"id":"bd34b2d6-18df-44a7-bc92-bc2097598fe9","acronym":"","url":"https://clinicaltrials.gov/study/NCT02289196","created_at":"2021-06-30T14:52:42.647Z","updated_at":"2024-07-02T16:36:58.791Z","phase":"Phase 1","brief_title":"Safety Study of Vx006 Vaccine in Solid Tumor Patients","source_id_and_acronym":"NCT02289196","lead_sponsor":"Vaxon Biotech","biomarkers":" HLA-A","pipe":" | ","alterations":" HLA-A*02","tags":["HLA-A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Vx-006"],"overall_status":"Completed","enrollment":" Enrollment 23","initiation":"Initiation: 03/01/2014","start_date":" 03/01/2014","primary_txt":" Primary completion: 10/01/2014","primary_completion_date":" 10/01/2014","study_txt":" Completion: 05/01/2017","study_completion_date":" 05/01/2017","last_update_posted":"2019-06-19"}]